focus -WSS

focus

author：entertainment 2025-08-28 08:40:43 - browse：5

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

WSS

What Henrietta Lacks settlement says about racism in medicine

Food makers tried to stack nutrition panel with preferred experts

PEPFAR is under serious threat — and so is global health

FDA approves updated Covid vaccines

White House drug shortage group privately met with industry

Popular nasal decongestant doesn't actually relieve congestion

focus

focus

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

ProMED, early warning system on disease outbreaks, in peril

Medicare proposal to cover medical devices draws a mixed reaction

Influencer to be charged after chaos erupts in New York City's Union Square

What does generative AI mean for health care? We asked experts

FDA panel endorses Alnylam’s heart drug — after picking it apart

United colonoscopy coverage change 'may cost lives,' doctors say

Pig kidney works a record two months in donated body

United colonoscopy coverage change 'may cost lives,' doctors say

'Ancient DNA,' 23andMe reveal African American ancestries

Wikipedia

Humana, CVS hope to turn members into patients at clinics

Telehealth for opioid use disorder is lifesaving

The drug industry sees a key ally in the Senate prevail

Regeneron agrees to White House price limits on anti

Telehealth for opioid use disorder is lifesaving

Biden calls for immediate release of Niger's president amid apparent coup

Wikipedia

focus

leisure time

focus